Celyad Oncology S.A.

CYAD.BR · BRU
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-€6-€8-€41-€27
Dep. & Amort.€0€1€1€2
Deferred Tax€0€0€0-€1
Stock-Based Comp.€0€1€2€2
Change in WC-€0-€1-€4€1
Other Non-Cash-€0-€7€14-€5
Operating Cash Flow-€6-€15-€28-€27
Investing Activities
PP&E Inv.-€0-€1-€0-€0
Net Acquisitions€0€0€6€0
Inv. Purchases€0€0€0€0
Inv. Sales/Matur.€0€0€1€0
Other Inv. Act.€0€1€0€0
Investing Cash Flow-€0€0€7-€0
Financing Activities
Debt Repay.-€0-€0-€1-€1
Stock Issued€0€9€0€37
Stock Repurch.€0€0-€0€0
Dividends Paid€0€0€0€0
Other Fin. Act.€3€0€4€4
Financing Cash Flow€3€9€3€40
Forex Effect-€0-€0-€0€0
Net Chg. in Cash-€3-€5-€18€13
Supplemental Information
Beg. Cash€7€12€30€17
End Cash€4€7€12€30
Free Cash Flow-€6-€16-€28-€27
Celyad Oncology S.A. (CYAD.BR) Financial Statements & Key Stats | AlphaPilot